PERSISTENCE OF LYMPHOCYTIC CHORIOMENINGITIS VIRUS IN IMMUNE ANIMALS AND ITS RELATION TO IMMUNITY

E Traub1

  • 1Department of Animal and Plant Pathology of The Rockefeller Institute for Medical Research, Princeton, N. J.

Insights

The lymphocytic choriomeningitis virus can persist in recovered mice, suggesting tissue-linked immunity rather than circulating antibodies or leucocytes. This viral persistence may be linked to organ lesions.

Area of Science:

  • Virology
  • Immunology
  • Infectious Diseases

Background:

  • The Lymphocytic choriomeningitis virus (LCMV) can persist in seemingly healthy individuals post-recovery.
  • Understanding the mechanisms of viral persistence and immunity is crucial for disease management.

Purpose of the Study:

  • To investigate the persistence of LCMV in mice after recovery.
  • To explore the role of circulating antibodies and leucocytes in LCMV immunity.
  • To determine the relationship between viral persistence and organ lesions.

Main Methods:

  • Monitoring LCMV presence in blood, urine, and nasal secretions of infected mice.
  • Assessing the presence of antivirus in sera of immune mice.
  • Evaluating the role of leucocytes in immunity.
  • Examining LCMV presence in urine and blood of recovered guinea pigs.

Main Results:

  • LCMV persisted in blood, urine, and nasal secretions of some recovered mice, potentially due to lung, liver, and kidney lesions.
  • Immunity in mice did not correlate with the presence of virus in blood or organs.
  • Circulating antivirus and leucocytes were not essential factors for immunity in mice.
  • Recovered guinea pigs from severe LCMV infections shed virus in urine, but not blood, while antivirus was detected in their blood.

Conclusions:

  • LCMV immunity in mice is likely tissue-associated, not dependent on circulating antivirus or leucocytes.
  • Viral persistence post-recovery may be influenced by organ damage.
  • Further research is needed to elucidate the exact mechanisms of LCMV persistence and immunity.

Related Concept Videos

Immunological Memory01:23

Immunological Memory

Immunological memory, a pivotal pillar of the adaptive immune system, is responsible for the body's ability to remember and respond more swiftly and effectively to previously encountered pathogens. This remarkable feature is what makes vaccines so effective in preventing diseases.
What is Immunological Memory?
Immunological memory is an integral function of the immune system that allows it to recognize and react more rapidly and effectively to pathogens previously encountered. This feature is...
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
Vaccines01:21

Vaccines

Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...
Malaria01:29

Malaria

Malaria pathogenesis in humans reflects a delicate interplay between parasite biology and host response. Clinical illness reflects a host’s immune response to the parasite’s asexual replication cycle, which is often asymptomatic in individuals with partial immunity. From the parasite's perspective, transmission between mosquito and human with minimal host pathology is evolutionarily advantageous. Among the six Plasmodium species infecting humans, P. falciparum and P. vivax dominate in global...